No Data
OncoTherapy Science: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)
OTS and others continue to rank in, signing a joint research agreement with the Medical Foundation for Health and Nutrition Research Institute.
OTS <4564> ranked in (as of 1:33 pm). Significantly higher. It seems that they have announced a joint research agreement with the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN, Veon Ltd Ads) regarding the development and application of drug discovery platforms utilizing AI before the start of today's trading, which is driving buying interest. By utilizing NIBIOHN's AI-based drug discovery platform technology, they aim to analyze our proprietary compound information and explore compounds that lead to new drug discovery.
Volume Change Rate Ranking (9 o'clock) - Headwater, Enechange, etc. are ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in speculation by comparing the average volume of the last 5 days with the volume on the delivery date. Top volume change rate [As of 9:32 on October 7] (Comparison with average volume of the last 5 days) Stock Code Stock Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <3395> Sanmark HD 184,200 107,185.08 236.45% 0.076
The Tokyo Stock Exchange Growth Market Index fell slightly, lacking direction for the day.
Tokyo Stock Exchange Growth Market Index 852.05 -1.71 / Volume 0.2 billion 3.11 million shares / Trading value 127.2 billion yen Tokyo Stock Exchange Growth Market 250 Index 667.65 -1.36 / Volume 0.1 billion 12.09 million shares / Trading value 104.8 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, experienced a slight decline. The number of rising stocks is 226, the number of declining stocks is 325, and unchanged stocks are 36. In the US market on the 30th, the Dow Jones Average was up 228.03 dollars to 41563.
Emerging markets outlook: The 200-day moving average is acting as resistance, will the search for low-priced stocks continue through the process of elimination?
■The main stocks had a strong start this week and the emerging markets saw a significant increase. During the same period, while the Nikkei Average rose by +0.74%, the Growth Market Index rose by +4.09% and the Growth Market 250 Index rose by +4.45%, highlighting the rise in emerging markets. The trading volume remained in the 100-billion-yen range and trading did not increase, but the index rose due to the strong movement of large-cap stocks with a large market capitalization at the beginning of the week. The Growth Market 250 Index reached its 200-day moving average line since July 19th. After reaching it...
Emerging market stocks digest: RentRacks hits a new high for the year, KuFuu Company soars.
<4564> OTS 54 +3 rebound. After the close of trading on the 23rd, WOLVES HAND, a consolidated subsidiary, announced that it has signed a joint research contract with Cancer Precision Medicine in the field of veterinary medicine for early detection of cancer through liquid biopsy. It is considered to be a positive factor. In the future, it will sample cfDNA in the plasma of dogs and cats over time and perform liquid biopsies at the Veterinary Advanced Medical Research Institute.
No Data
No Data